[1] Wu, Z.; Zhou, Z.K.; Gilbert, M.G. Morus L. Flora China. 2003, 5, 22-26.
[2] Chan, E.W.C.; Lye, P.Y.; Wong, S.K. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin. J. Nat. Med. 2016, 14, 17-30.
[3] Ercisli, S.; Orhan, E. Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits. Food Chem. 2007, 103, 1380-1384.
[4] Wei, H.; Zhu, J.J.; Liu, X.Q.; Feng, W.H.; Wang, Z.M.; Yan, L.H. Review of bioactive compounds from root barks of Morus plants (Sang-Bai-Pi) and their pharmacological effects. Cogent Chem. 2016, 2, 1212320.
[5] Singab, A.N.; El-Beshbishy, H.A.; Yonekawa, M.; Nomura, T.; Fukai, T. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2005, 100, 333-338.
[6] El-Beshbishy, H.A.; Singab, A.N.; Sinkkonen, J.; Pihlaja, K. Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci. 2006, 78, 2724-2733.
[7] Khan, M.A.; Rahman, A.A.; Islam, S.; Khandokhar, P.; Parvin, S.; Islam, M.B.; Hossain, M.; Rashid, M.; Sadik, G.; Nasrin, S.; Haque Mollah, M.N.; Khurshid Alam, A.H.M. A comparative study on the antioxidant activity of methanolic extracts from different parts of Morus alba L. (Moraceae). BMC Res. Notes. 2013, 6, 24.
[8] Kim, H.J.; Lee, H.J.; Jeong, S.J.; Lee, H.J.; Kim, S.H.; Park, E.J. Cortex Mori Radicis extract exerts anti-asthmatic effects via enhancement of CD4+ CD25+ Foxp3+ regulatory T cells and inhibition of Th2 cytokines in a mouse asthma model. J. Ethnopharmacol. 2011, 138, 40-46.
[9] Kang, K.B.; Lee, D.Y.; Kim, T.B.; Kim, S.H.; Kim, H.J.; Kim, J.; Sung, S.H. Prediction of tyrosinase inhibitory activities of Morus alba root bark extracts from HPLC fingerprints. Microchem. J. 2013, 110, 731-738.
[10] Yang, Z.G.; Matsuzaki, K.; Takamatsu, S.; Kitanaka, S. Inhibitory effects of constituents from Morus alba var. multicaulis on differentiation of 3T3-L1 cells and nitric oxide production in RAW264.7 cells. Molecules. 2011, 16, 6010-6022.
[11] Lee, M.S.; Park, W.S.; Kim, Y.H.; Kwon, S.H.; Jang, Y.J.; Han, D.; Morita, K.; Her, S. Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus. Behav. Brain Res. 2013, 236, 56-61.
[12] Lim, H.J.; Jin, H.G.; Woo, E.R.; Lee, S.K.; Kim, H.P. The root barks of Morus alba and the flavonoid constituents inhibit airway inflammation. J. Ethnopharmacol. 2013, 149, 169-175.
[13] Eo, H.J.; Park, J.H.; Park, G.H.; Lee, M.H.; Lee, J.R.; Koo, J.S.; Jeong, J.B. Anti-inflammatory and anti-cancer activity of mulberry (Morus alba L.) root bark. BMC Complement. Alternat. Med. 2014, 14, 200.
[14] Nam, S.Y.; Yi, H.K.; Lee, J.C.; Kim, J.C.; Song, C.H.; Park, J.W.; Lee, D.Y.; Kim, J.S.; Hwang, P.H. Cortex mori extract induces cancer cell apoptosis through inhibition of microtubule assembly. Arch. Pharm. Res. 2002, 25, 191-196.
[15] Chen, H.D.; Ding, Y.Q.; Yang, S.P.; Li, X.C.; Wang, X.J.; Zhang, H.Y.; Ferreira, D.; Yue, J.M. Morusalbanol A, a neuro-protective Diels-Alder adduct with an unprecedented architecture from Morus alba. Tetrahedron. 2012, 68, 6054-6058.
[16] Yin, N.; Hong, X.; Han, Y.; Duan, Y.; Zhang, Y.; Chen, Z. Cortex Mori Radicis extract induces neurite outgrowth in PC12 cells activating ERK signalling pathway via inhibiting Ca2+ influx. Int. J. Clin. Exper. Med. 2015, 8, 5022-5032.
[17] Kuk, E.B.; Jo, A.R.; Oh, S.I.; Sohn, H.S.; Seong, S.H.; Roy, A.; Choi, J.S.; Jung, H.A. Anti-Alzheimer’s disease activity of compounds from the root bark of Morus alba L. Arch. Pharm. Res. 2017, 40, 338-349.
[18] Ha, M.T.; Tran, M.H.; Ah, K.J.; Jo, K.J.; Kim, J.; Kim, W.D.; Cheon, W.J.; Woo, M.H.; Ryu, S.H.; Min, B.S. Potential pancreatic lipase inhibitory activity of phenolic constituents from the root bark of Morus alba L. Bioorg. Med. Chem. Lett. 2016, 26, 2788-2794.
[19] Qi, S.Z.; Li, N.; Tuo, Z.D.; Li, J.L.; Xing, S.S.; Li, B.B.; Zhang, L.; Lee, H.S.; Chen, J.G.; Cui, L. Effects of Morus root bark extract and active constituents on blood lipids in hyperlipidemia rats. J. Ethnopharmacol. 2016, 180, 54-59.
[20] Lian, J.; Chen, J.; Yuan, Y.; Chen, J.; Sayed, M.D.; Luo, L.; Zhu, Y.; Li, S.; Bu, S. Cortex Mori Radicis extract attenuates myocardial damages in diabetic rats by regulating ERS. Biomed. Pharmacother. 2017, 90, 777-785.
[21] Zheng, X.K.; Cao, Y.G.; Ke, Y.Y.; Zhang, Y.L.; Li, F.; Gong, J.H.; Zhao, X.; Kuang, H.X.; Feng, W.S. Phenolic constituents from the root bark of Morus alba L. and their cardioprotective activity in vitro. Phytochemistry. 2017, 135, 128-134.
[22] Zuo, G.Y.; Yang, C.X.; Han, J.; Li, Y.Q.; Wang, G.C. Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates. Phytomedicine. 2018, 39, 93-99.
[23] Yuvaraj, K.; Arumugam, G. Anti-inflammatory and preventive activity of white mulberry root bark extract in an experimental model of pancreatitis. J. Tradit. Complement. Med. 2018, 1-9.
[24] Butt, M.S.; Nazir, A.; Sultan, M.T.; Schroën, K. Morus alba L. nature’s functional tonic. Trends Food Sci. Technol. 2008, 19, 505-512.
[25] Devi, B.; Sharma, N.; Kumar, D.; Jeet, K. Morus alba Linn: A phytopharmacological review. Int. J. Pharm. Pharm. Sci. 2013, 5, 14-18.
[26] Singh, R.; Bagachi, A.; Semwal, A.; Kaur, S.; Bharadwaj, A. Traditional uses, phytochemistry and pharmacology of Morus alba Linn: A review. J. Med. Plants Res. 2013, 7, 461-469.
[27] Zafar, M.S.; Muhammad, F.; Javed, I.; Akhtar, M.; Khaliq, T.; Aslam, B.; Waheed, A.; Yasmin, R.; Zafar, H. White mulberry (Morus alba): A brief phytochemical and pharmacological evaluations account. Int. J. Agric. Biol. 2013, 15, 612-620.
[28] Hussain, F.; Rana, Z.; Shafique, H.; Malik, A.; Hussain, Z. Phytopharmacological potential of different species of Morus alba and their bioactive phytochemicals: A review. Asian Pac. J. Trop. Biomed. 2017, 7, 950-956.
[29] Kikuchi, T.; Nihei, M.; Nagai, H.; Fukushi, H.; Tabata, K.; Suzuki, T.; Akihisa, T. Albanol A from the root bark of Morus alba L. induces apoptotic cell death in HL60 human leukemia cell line. Chem. Pharm. Bull. 2010, 58, 568-571.
[30] Qin, J.; Fan, M.; He, J.; Wu, X.D.; Peng, L.Y.; Su, J.; Cheng, X.; Li, Y.; Kong, L.M.; Li, R.T.; Zhao, Q.S. New cytotoxic and anti-inflammatory compounds isolated from Morus alba L. Nat. Prod. Res. 2015, 29, 1711-1718.
[31] Guo, Y.Q.; Tang, G.H.; Lou, L.L.; Li, W.; Zhang, B.; Liu, B.; Yin, S. Prenylated flavonoids as potent phosphodiesterase-4 inhibitors from Morus alba: Isolation, modification, and structure-activity relationship study. Eur. J. Med. Chem. 2018, 144, 758-766.
[32] Yang, D.S.; Li, Z.L.; Yang, Y.P.; Xiao, W.L.; Li, X.L. A new geranylated 2-arylbenzofuran from Morus alba. Chin. Herbal Med. 2015, 7, 191-194.
[33] Geng, C.A.; Yao, S.; Xue, D.; Zuo, A.; Zhang, X.; Jiang, Z.; Ma, Y.; Chen, J. New isoprenylated flavonoid from Morus alba. China J. Chin. Mater. Med. 2010, 35, 1560-1565.
[34] Nomura, T.; Fukai, T.; Yamada, S.; Katayanagi, M. Phenolic constituents of the cultivated mulberry tree (Morus alba L.). Chem. Pharm. Bull. 1976, 24, 2898-2900.
[35] Du, J.; He, Z.D.; Jiang, R.W.; Ye, W.C.; Xu, H.X.; But, P.P. Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry. 2003, 62, 1235-1238.
[36] Jung, J.W.; Ko, W.M.; Park, J.H.; Seo, K.H.; Oh, E.J.; Lee, D.Y.; Lee, D.S.; Kim, Y.C.; Lim, D.W.; Han, D.; Baek, N.I. Isoprenylated flavonoids from the root bark of Morus alba and their hepatoprotective and neuroprotective activities. Arch. Pharm. Res. 2015, 38, 2066-2075.
[37] Zhao, Y.; Kongstad, K.T.; Jäger, A.K.; Nielsen, J.; Staerk, D. Quadruple high-resolution α-glucosidase/α-amylase/PTP1B/radical scavenging profiling combined with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for identification of antidiabetic constituents in crude root bark of Morus alba L. J. Chromatogr. A. 2018, 1556, 55-63.
[38] Nomura, T. Chemistry and biosynthesis of prenylflavonoids. J. Pharm. Soc. Jpn. 2001, 121, 535-556.
[39] Li, M.; Wu, X.; Wang, X.; Shen, T.; Ren, D. Two novel compounds from the root bark of Morus alba L. Nat. Prod. Res. 2018, 32, 36-42.
[40] Huang, Q.H.; Lei, C.; Wang, P.P.; Li, J.Y.; Li, J.; Hou, A.J. Isoprenylated phenolic compounds with PTP1B inhibition from Morus alba. Fitoterapia. 2017, 122, 138-143.
[41] Nomura, T.; Fukai, T.; Katayanagi, M. Isolation of four new flavones, kuwanon A, B, C, and oxydihydromorusin from the root bark of Morus alba L. Chem. Pharm. Bull. 1978, 26, 1453-1458.
[42] Nomura, T.; Fukai, T. Kuwanon G, a new flavone derivative from the root barks of the cultivated mulberry tree (Morus alba L.). Chem. Pharm. Bull. 1980, 28, 2548-2552.
[43] Ueda, S.; Matsumoto, J.; Nomura, T. Four new natural Diels-Alder type adducts, mulberrofuran E, kuwanon Q, R, and V from callus culture of Morus alba L. Chem. Pharm. Bull. 1984, 32, 350-353.
[44] Park, K.M.; You, J.S.; Lee, H.Y.; Baek, N.I.; Hwang, J.K. Kuwanon G: an antibacterial agent from the root bark of Morus alba against oral pathogens. J. Ethnopharmacol. 2003, 84, 181-185.
[45] Cui, L.; Na, M.; Oh, H.; Bae, E.Y.; Jeong, D.G.; Ryu, S.E.; Kim, S.; Kim, B.Y.; Oh, W.K.; Ahn, J.S. Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg. Med. Chem. Lett. 2006, 16, 1426-1429.
[46] Lee, J.J.; Yang, H.; Yoo, Y.M.; Hong, S.S.; Lee, D.; Lee, H.J.; Lee, H.J.; Myung, C.S.; Choi, K.C.; Jeung, E.B. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease. J. Atheroscler. Thromb. 2012, 19, 516-522.
[47] Zhang, M.; Rong-Rong, W.A.; Man, C.H.; Zhang, H.Q.; Shi, S.U.; Zhang, L.Y. A new flavanone glycoside with anti-proliferation activity from the root bark of Morus alba. Chin. J. Nat. Med. 2009, 7, 105-107.
[48] Fu, W.; Lei, Y.F.; Cai, Y.L.; Zhou, D.N.; Ruan, J.L. A new alkylene dihydrofuran glycoside with antioxidation activity from the root bark of Morus alba L. Chin. Chem. Lett. 2010, 21, 821-823.
[49] Nomura, T.; Fukai, T.; Uno, J.; Arai, T. Mulberrofuran A, a new isoprenoid 2-arylbenzofuran from root bark of cultivated mulberry tree (Morus alba L). Heterocycles. 1978, 9, 1593-1601.
[50] Nomura, T.; Fukai, T. Mulberrofuran B, a new isoprenoid 2-arylbenzofuran from the root bark of the cultivated mulberry tree. Planta Med. 1981, 42, 197-199.
[51] Zhang, M.; Chen, M.; Zhang, H.Q.; Sun, S.; Xia, B.; Wu, F.H. In vivo hypoglycemic effects of phenolics from the root bark of Morus alba. Fitoterapia. 2009, 80, 475-477.
[52] Qiu, F.; Komatsu, K.; Kawasaki, K.; Saito, K.; Yao, X.; Kano, Y. A novel stilbene glucoside, oxyresveratrol 3’-O-β-glucopyranoside, from the root bark of Morus alba. Planta Med. 1996, 62, 559-561.
[53] Jung, J.W.; Park, J.H.; Jung, Y.J.; Lee, C.H.; Han, D.; Baek, N.I. Isolation and identification of triterpenoids from the mulberry (Morus alba) root bark. J. Appl. Biol. Chem. 2014, 57, 295-299.
[54] Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333.
[55] Keservani, R.K.; Sharma, A.K. Flavonoids: emerging trends and potential health benefits. J. Chin. Pharm. Sci. 2014, 23, 815-822.
[56] Khanam, H.; Shamsuzzaman. Bioactive benzofuran derivatives: A review. Eur. J. Med. Chem. 2015, 97, 483-504.
[57] Han, X.; Shen, T.; Lou, H. Dietary polyphenols and their biological significance. Int. J. Mol. Sci. 2007, 8, 950-988.
[58] Patočka, J. Biologically active pentacyclic triterpenes and their current medicine signification. J. Appl. Biomed. 2003, 1, 7-12.
[59] Furtado, N.A.J.C.; Pirson, L.; Edelberg, H.; Miranda, L.M.; Loira-Pastoriza, C.; Preat, V.; Larondelle, Y.; André, C.M. Pentacyclic triterpene bioavailability: an overview of in vitro and in vivo studies. Molecules. 2017, 22, 400.
[60] Robbins, R.J. Phenolic acids in foods: an overview of analytical methodology. J. Agric. Food Chem. 2003, 51, 2866-2887.
[61] Balasundram, N.; Sundram, K.; Samman, S. Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses. Food Chem. 2006, 99, 191-203.
[62] Bubols, G.B.; da Rocha Vianna, D.; Medina-Remon, A.; von Poser, G.; Lamuela-Raventos, R.M.; Eifler-Lima V.L.; Cristina Garcia, S. The antioxidant activity of coumarins and flavonoids. Mini-Rev. Med. Chem. 2013, 13, 318-334.
[63] Hano, Y; Nomura, T. Constituents of the Chinese crude drug Sang-Bai-Pi (Morus root barks) IV. Structures of four new flavonoids, sanggenon H, I, J and K. Heterocycles. 1983, 20, 1071-1076.
[64] Hano, Y.; Ichikawa, K.; Okuyama, M.; Yamanaka, J.; Miyoshi, T.; Nomura, T. Sanggenons R, S, and T, three new isoprenylated phenols from the Chinese crude drug Sang-Bai-Pi (Morus root bark). Heterocycles. 1995, 2, 953-965.
[65] Hano, Y.; Kohno, H.; Itoh, M.; Nomura, T. Structures of three new 2-arylbenzofuran derivatives from the Chinese crude drug Sang-Bai-Pi (Morus root bark). Chem. Pharm. Bull. 1985, 33, 5294-5300.
[66] Dat, N.T.; Binh, P.T.; van Minh, C.; Huong, H.T.; Lee, J.J. Cytotoxic prenylated flavonoids from Morus alba. Fitoterapia. 2010, 81, 1224-1227.
[67] Gupta, G.; Dua, K.; Kazmi, I.; Anwar, F. Anticonvulsant activity of morusin isolated from Morus alba: Modulation of GABA receptor. Biomed. Aging Pathol. 2014, 4, 29-32.
[68] Tran, H.N.; Nguyen, V.T.; Kim, J.A.; Rho, S.S.; Woo, M.H.; Choi, J.S.; Lee, J.H.; Min, B.S. Anti-inflammatory activities of compounds from twigs of Morus alba. Fitoterapia. 2017, 120, 17-24.
[69] Vochyánová, Z.; Pokorná, M.; Rotrekl, D.; Smékal, V.; Fictum, P.; Suchý, P.; Gajdziok, J.; Šmejkal, K.; Hošek, J. Prenylated flavonoid morusin protects against TNBS-induced colitis in rats. PLoS One. 2017, 12, e0182464.
[70] Terao, J.; Mukai, R. Prenylation modulates the bioavailability and bioaccumulation of dietary flavonoids. Arch. Biochem. Biophy. 2014, 559, 12-16.
[71] Tseng, T.H.; Chuang, S.K.; Hu, C.C.; Chang, C.F.; Huang, Y.C.; Lin, C.W.; Lee, Y.J. The synthesis of morusin as a potent anti-tumour agent. Tetrahedron. 2010, 66, 1335-1340.
[72] Lim, S.L.; Park, S.Y.; Kang, S.; Park, D.; Kim, S.H.; Um, J.Y.; Jang, H.J.; Lee, J.H.; Jeon, C.H.; Jang, J.H.; Ahn, K.S.; Lee, S.G. Morusin induces cell death through inactivating STAT3 signalling in prostate cancer cells. Amer. J. Cancer Res. 2015, 5, 289-299.
[73] Kang, S.; Kim, E.O.; Kim, S.H.; Lee, J.H.; Ahn, K.S.; Yun, M.; Lee, S.G. Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells. Oncol. Lett. 2017, 13, 4558-4562.
[74] Li, H.; Wang, Q.; Dong, L.; Liu, C.; Sun, Z.; Gao, L.; Wang, X. Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis. J. Exper. Clin. Cancer Res. 2015, 34, 137.
[75] Lee, J.C.; Won, S.J.; Chao, C.L.; Wu, F.L.; Liu, H.S.; Ling, P.; Lin, C.N.; Su, C.L. Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells. Biochem. Biophy. Res. Commun. 2008, 372, 236-242.
[76] Wang, L.; Guo, H.; Yang, L.; Dong, L.; Lin, C.; Zhang, J.; Lin, P.; Wang, X. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction. Mol. Cell. Biochem. 2013, 379, 7-18.
[77] Lin, W.L.; Lai, D.Y.; Lee, Y.J.; Chen, N.F.; Tseng, T.H. Anti-tumour progression potential of morusin suppressing STAT3 and NF-κB in human hepatoma SK-Hep1 cells. Toxicol. Lett. 2015, 232, 490-498.
[78] Kim, C.; Kim, J.H.; Oh, E.Y.; Nam, D.; Lee, S.G.; Lee, J.; Kim, S.H.; Shim, B.S.; Ahn, K.S. Blockage of STAT3 signalling pathway by morusin induces apoptosis and inhibits invasion in human pancreatic tumour cells. Pancreas. 2016, 45, 409-419.
[79] Ding, B.; Lv, Y.; Zhang, Y.Q. Anti-tumour effect of morusin from the branch bark of cultivated mulberry in Bel-7402 cells via the MAPK pathway. RSC Adv. 2016, 6, 17396-17404.
[80] Park, D.; Ha, I.J.; Park, S.Y.; Choi, M.; Lim, S.L.; Kim, S.H.; Lee, J.H.; Ahn, K.S.; Yun, M.; Lee, S.G. Morusin induces TRAIL sensitization by regulating EGFR and DR5 in human glioblastoma cells. J. Nat. Prod. 2016, 79, 317-323.
[81] Wang, F.; Zhang, D.; Mao, J.; Ke, X.X.; Zhang, R.; Yin, C.; Gao, N.; Cui, H. Morusin inhibits cell proliferation and tumour growth by down-regulating c-Myc in human gastric cancer. Oncotarget. 2017, 8, 57187.
[82] Yin, X.L.; Lv, Y.; Wang, S.; Zhang, Y.Q. Morusin suppresses A549 cell migration and induces cell apoptosis by down-regulating the expression of COX-2 and VEGF genes. Oncol. Rep. 2018, 40, 504-510.
[83] Guo, H.; Liu, C.; Yang, L.; Dong, L.; Wang, L.; Wang, Q.; Li, H.; Zhang, J.; Lin, P.; Wang, X. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte trans-differentiation, and apoptosis induction. Mol. Carcinogen. 2016, 55, 77-89.
[84] Cho, S.W.; Na, W.; Choi, M.; Kang, S.J.; Lee, S.G.; Choi, C.Y. Autophagy inhibits cell death induced by the anti-cancer drug morusin. Amer. J. Cancer Res. 2017, 7, 518-530.
[85] Gao, L.; Wang, L.; Sun, Z.; Li, H.; Wang, Q.; Yi, C.; Wang, X. Morusin shows potent anti-tumour activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition. Drug Design Dev. Ther. 2017, 11, 1789-1802.
[86] Xue, J.; Li, R.; Zhao, X.; Ma, C.; Lv, X.; Liu, L.; Liu, P. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer. Chem-Biol. Interact. 2018, 283, 59-74.
[87] Lee, H.J.; Ryu, J.; Park, S.H.; Woo, E.R.; Kim, A.R.; Lee, S.K.; Yim, Y.S.; Kim, J.O.; Hong, J.H.; Lee, C.J. Effects of Morus alba L. and natural products including morusin on in vivo secretion and in vitro production of airway MUC5AC mucin. Tuberc. Respir. Dis. 2014, 77, 65-72.
[88] Gupta, G.; Dua, K.; Kazmi, I.; Anwar, F. Anticonvulsant activity of morusin isolated from Morus alba: Modulation of GABA receptor. Biomed. Aging Pathol. 2014, 4, 29-32.
[89] De Souza, M.M.; Bittar, M.; Cechinel-Filho, V.; Yunes, R.A.; Messana, I.; Delle Monache, F.; Ferrari, F. Antinociceptive properties of morusin, a prenylflavonoid isolated from Morus nigra root bark. Z. Naturforsch. C. 2000, 55, 256-260.
[90] Gupta, G.; Chellappan, D.K.; Agarwal, M.; Ashwathanarayana, M.; Nammi, S.; Pabreja, K.; Dua, K. Pharmacological evaluation of the recuperative effect of morusin against aluminium trichloride (AlCl3)-induced memory impairment in rats. Cent. Nerv. Syst. Agents Med. Chem. 2017, 17, 196-200.
[91] Cheng, P.S.; Hu, C.C.; Wang, C.J.; Lee, Y.J.; Chung, W.C.; Tseng, T.H. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P+ mouse epidermal cells. Chem-Biol. Interact. 2017, 264, 34-42.
[92] Shi-De, L.; Nemec, J.; Bing-Mei, N. Anti-HIV flavonoids from Morus alba. Acta Bot. Yunnanica. 1995, 17, 89-95. |